tiprankstipranks
Trending News
More News >
Chimerix Hold Rating: Financial Constraints and Revised EPS Outlook Influence Cautious Recommendation
PremiumRatingsChimerix Hold Rating: Financial Constraints and Revised EPS Outlook Influence Cautious Recommendation
3M ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
3M ago
Jazz Pharmaceuticals price target raised to $230 from $220 at Truist
Premium
The Fly
Jazz Pharmaceuticals price target raised to $230 from $220 at Truist
3M ago
Chimerix downgraded to Hold from Buy at Jefferies
PremiumThe FlyChimerix downgraded to Hold from Buy at Jefferies
3M ago
CrowdStrike reports Q4 beat, Jazz to acquire Chimerix: Morning Buzz
Premium
The Fly
CrowdStrike reports Q4 beat, Jazz to acquire Chimerix: Morning Buzz
3M ago
Hold Rating Issued Amidst Chimerix Acquisition by Jazz Pharmaceuticals
Premium
Ratings
Hold Rating Issued Amidst Chimerix Acquisition by Jazz Pharmaceuticals
3M ago
Jazz Pharmaceuticals to acquire Chimerix for $8.55 per share in cash, or $935M
PremiumThe FlyJazz Pharmaceuticals to acquire Chimerix for $8.55 per share in cash, or $935M
3M ago
Jazz Pharmaceuticals to acquire Chimerix for $8.55 per share in cash
Premium
The Fly
Jazz Pharmaceuticals to acquire Chimerix for $8.55 per share in cash
3M ago
Chimerix’s Strategic Pause and Financial Strength Bolster Long-term Buy Rating Amid Regulatory Milestones
Premium
Ratings
Chimerix’s Strategic Pause and Financial Strength Bolster Long-term Buy Rating Amid Regulatory Milestones
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100